drugset
drugset / Trial / NCT03565094

Single Dose of Lu AF28996 to Healthy Young Men

NCT03565094 ↗

Phase 1 Completed 39 enrolled H. Lundbeck A/S
NaSingle-groupOpen-labelTreatment

Summary

This study evaluates how increasing doses of Lu AF28996 enters, moves through and exits the body when given by mouth to healthy young men.

Timeline

Start
2018-05-29
Primary completion
2019-08-17
Completion
2019-08-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AF28996 Unknown — Oral

Indications

No indication recorded.